• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Hydrolyzed formula in susceptible infants does not reduce Diabetes-linked autoantibodies

byReshmi MadankumarandPriyanka Vedak
June 11, 2014
in Chronic Disease, Endocrinology, Gastroenterology, Pediatrics
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Compared to the use of traditional cow’s milk-based formula, the use of hydrolyzed formula in genetically susceptible infants did not significantly reduce the number β-cell autoimmunity-related antibodies detected after 7 years. 

Evidence Rating Level: 1 (Excellent)       

Study Rundown: Type 1 diabetes is an autoimmune disorder in which the destruction of pancreatic β-islet cells results in insulin deficiency. Current evidence suggests that infantile exposure to complex proteins in genetically susceptible individuals may increase the risk of developing β-cell autoimmunity-related antibodies later in life. These antibodies can act as markers that may help predict the eventual development of β-cell autoimmunity and type 1 diabetes.

This study tested the hypothesis that providing an infant with a highly hydrolyzed formula would decrease the later development of autoantibodies and thus B-cell autoimmunity. It compared the use of highly hydrolyzed casein formula versus cow’s milk based formula in genetically susceptible infants. The primary outcome was positivity for > 2 autoantibodies over a period of 7 years.

This study was limited in its generalizability due to its inclusion of only genetically susceptible infants. Additionally, the role of breastfeeding in antibody development was not examined. Thus, future studies may aim to increase the generalizability of findings and capture the effects of breastfeeding on these outcome measures. Nevertheless, this study does not demonstrate a benefit to using hydrolyzed formula in infants at high risk for type 1 diabetes at this time.

Click to read the study, published today in JAMA

Relevant Reading: The Trial to Reduce IDDM in the Genetically at Risk (TRIGR) study: recruitment, intervention and follow-up

RELATED REPORTS

Sodium-glucose cotransporter 2 inhibitors may reduce incidence of obstructive airway disease

Metformin use in Type 2 Diabetes associated with decreased risk of joint replacement

Low-carbohydrate, high-fat diet improves glycemic control in type 2 diabetic patients

In-Depth [randomized controlled trial]: This study was a randomized controlled trial in which infants with HLA susceptibility and a first-degree relative with type 1 diabetes were randomized to either the casein hydrolyzed formula group (n=1081) or the cow’s milk formula group (n=1078). Islet cell antibodies were detected using indirect immunofluorescence and insulin autoantibodies, glutamic acid decarboxylase autoantibodies and tyrosine phosphatase-related insulinoma-associated molecule were detected with specific radiobinding assays. Over a median period of 7 years, 139 infants (13.4%) in the hydrolyzed formula group demonstrated positivity for > 2 autoantibodies versus 117 infants (11.4%) in the cow’s milk group formula group. The hazard risk for development of > 2 diabetes-associated autoantibodies in the hydrolyzed formula group was 1.21 (95% CI, 0.94-1.54), a statistically insignificant finding. The hazard risk for development of 1 autoantibody was 1.06 (95%CI, 0.93-1.22) and was also statistically insignificant.

More from this author: Prophylactic implantable cardioverter-defibrillators may decrease mortality in left ventricular dysfunction, The VIDA trial: Vitamin D3 does not improve outcomes in asthma patients

Image: PD

©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.  

Tags: diabetesformula
Previous Post

Diffusion-weighted MRI sensitive for metastasis in pelvic lymph nodes

Next Post

Levodopa for Parkinson’s disease more effective than newer generation therapies

RelatedReports

CPAP may not decrease cardiovascular events in sleep apnea
Endocrinology

Sodium-glucose cotransporter 2 inhibitors may reduce incidence of obstructive airway disease

February 2, 2023
Type 2 diabetes associated with reduction in disability-free life years
Chronic Disease

Metformin use in Type 2 Diabetes associated with decreased risk of joint replacement

January 16, 2023
Pediatric DKA associated with recent acute care visits
Cardiology

Low-carbohydrate, high-fat diet improves glycemic control in type 2 diabetic patients

January 11, 2023
Fewer work hours linked to greater likelihood of continued breastfeeding
Gastroenterology

Formula diets not associated with greater gastrointestinal intolerance than breast feeding

December 29, 2022
Next Post
Levodopa for Parkinson’s disease more effective than newer generation therapies

Levodopa for Parkinson’s disease more effective than newer generation therapies

ADHD stimulant treatment associated with changes in BMI trajectory

Combination CPAP, weight loss for obstructive sleep apnea offer no added benefit

Brodalumab effective in treating active psoriatic arthritis

Brodalumab effective in treating active psoriatic arthritis

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Factors associated with breastfeeding rates in Canada
  • Efanesoctocog alfa is efficacious in treating severe hemophilia A
  • Mavacamten associated with improvement in submaximal exertional tolerance: A secondary analysis of the EXPLORER-HCM randomized trial
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options